IMV Inc. — Investor Relations & Filings
IMV Inc. is a clinical-stage biopharmaceutical company specializing in immuno-oncology. The company is pioneering a novel class of cancer immunotherapies and vaccines for infectious diseases, such as RSV and COVID-19. Its core unique selling proposition is the proprietary immune-educating platform, known as DPX® technology. This platform is designed to make immunotherapies more effective and broadly applicable across various therapeutic areas, including cancer therapy and infectious diseases. IMV aims to advance its portfolio of DPX-based therapies through clinical development.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release - English.pdf | 2023-05-08 | English | |
| News release - English.pdf | 2023-03-31 | English | |
| News release - English.pdf | 2023-03-09 | English | |
| News release - English.pdf | 2023-02-13 | English | |
| News release - English.pdf | 2023-01-09 | English | |
| Material document(s).pdf | 2022-12-22 | English |
Browse filings by year
4 yearsMarket data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Toleranzia AB
A dissolved biotech company that developed therapies for au…
|
TOL | SE | Professional, scientific and te… |
|
ToolGen Incorporated
Biotechnology company developing genome editing for therape…
|
199800 | KR | Professional, scientific and te… |
|
Transcode Therapeutics, Inc.
Clinical-stage oncology company developing RNA-based therap…
|
RNAZ | US | Professional, scientific and te… |
|
Transgene
Develops cancer immunotherapies using vaccines and oncolyti…
|
TNG | FR | Professional, scientific and te… |
|
Transgene Biotek Ltd.
Develops oncology treatments, RNAi technology, and oral pro…
|
526139 | IN | Professional, scientific and te… |
|
TRANS GENIC GROUP INC.
Biotech firm offering drug discovery support and investment…
|
2342 | JP | Professional, scientific and te… |
|
Transition Therapeutics Inc.
Biopharmaceutical company developing drugs targeting CNS an…
|
TTH | CA | Professional, scientific and te… |
|
Trillium Therapeutics Inc.
Specialized in the discovery and development of innovative …
|
TRIL | CA | Professional, scientific and te… |
|
TriSalus Life Sciences, Inc.
Oncology company integrating drug delivery with immunothera…
|
TLSI | US | Professional, scientific and te… |
|
TRIVARX LTD
Develops AI-driven sleep analysis for mental health screeni…
|
TRI | AU | Professional, scientific and te… |
IMV Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/46116/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=46116 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=46116 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=46116 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 46116}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IMV Inc. (id: 46116)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.